Orchard Therapeutics plc Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Revenues
Product Revenue, Net
Collaboration Revenue
Total revenues
Costs and operating expenses
Cost of product revenue
Research and development
Selling general and administrative
Total costs and operating expenses
Loss from operations
Other (expense) income:
Interest income
Interest expense
Other (expense) income, net
Total other (expense) income, net
Net loss before income tax
Income tax (expense) benefit
Net loss attributable to ordinary shareholders
Net loss per share attributable to ordinary shareholders, basic and diluted
Weighted average number of ordinary shares outstanding, basic and diluted
Net loss per share attributable to ordinary shareholders, basic
Net loss per share attributable to ordinary shareholders, diluted
Weighted average number of ordinary shares outstanding, basic
Weighted average number of ordinary shares outstanding, diluted
Other comprehensive income (loss)
Foreign currency translation
Unrealized loss on marketable debt securities
Total other comprehensive income (loss)
Total comprehensive loss

Comments